The Medicare Part D drug benefit has hurt cross-border drug sales by as much as 30%, according to the Canadian International Pharmacy Association. The group also contends that U.S. authorities have stepped up enforcement of laws against drug importation in recent weeks.
Canadian mail order losing scripts to Part D
The Medicare Part D drug benefit has hurt cross-border drug sales by as much as 30%, according to the Canadian International Pharmacy Association. The group also contends that U.S. authorities have stepped up enforcement of laws against drug importation in recent weeks. The industry is considering marketing more heavily to the 45 million Americans with no health insurance to offset the loss of seniors.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.